Triazolothiadiazoles and triazolothiadiazines as potent α-glucosidase inhibitors: Mechanistic insights from kinetics studies, molecular docking and dynamics simulations

被引:19
作者
Ullah, Saeed [1 ]
Waqas, Muhammad [1 ,2 ]
Halim, Sobia Ahsan [1 ]
Khan, Imtiaz [3 ,4 ]
Khalid, Asaad [5 ]
Abdalla, Ashraf N. [6 ]
Makeen, Hafiz A. [7 ]
Ibrar, Aliya [8 ]
Khan, Ajmal [1 ]
Al-Harrasi, Ahmed [1 ]
机构
[1] Univ Nizwa, Nat & Med Sci Res Ctr, Nizwa 616, Oman
[2] Hazara Univ Mansehra, Dept Biotechnol & Genet Engn, Mansehra 21120, Pakistan
[3] Univ Manchester, Dept Chem, 131 Princess St, Manchester M1 7DN, England
[4] Univ Manchester, Manchester Inst Biotechnol, 131 Princess St, Manchester M1 7DN, England
[5] Jazan Univ, Subst Abuse & Toxicol Res Ctr, POB 114, Jazan 45142, Saudi Arabia
[6] Umm Al Qura Univ, Coll Pharm, Dept Pharmacol & Toxicol, Mecca 21955, Saudi Arabia
[7] Jazan Univ, Fac Pharm, Clin Pharm Dept, Pharm Practice Res Unit, Jazan, Saudi Arabia
[8] Univ Haripur, Dept Chem, Fac Phys & Appl Sci, Haripur 22620, Kpk, Pakistan
关键词
Triazolothiadiazole; Triazolothiadiazine; alpha-Glucosidase; Postprandial hyperglycaemia; Molecular docking; Molecular dynamics simulations; CRYSTAL-STRUCTURE; MICROBIOME; CHOLINESTERASE; PARAMETERS; SOFTWARE; LIBRARY; COMPLEX;
D O I
10.1016/j.ijbiomac.2023.126227
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Diabetes mellitus has been considered as a serious health problem worldwide due its high prevalence rate and associated complications. In this context, the current research work aims at exploring new structural leads for the treatment of a major metabolic disorder, diabetes mellitus type 2. The outcomes of our prior studies on a diverse set of triazolothiadiazole and triazolothiadiazine derivatives and their therapeutic potential, encouraged us to explore their anti-diabetic competency by targeting the key carbohydrate catabolic enzyme, alpha-glucosidase. Therefore, all these analogues were examined to reveal their contribution towards this severe metabolic issue. Interestingly, all the tested compounds (2a-2l and 3a-3p) exhibited several times more potent alpha-glucosidase inhibitory activities (IC50 in the range of 2.44-219.93 mu M) as compared to marketed drug, acarbose (IC50 = 873.34 +/- 1.67 mu M). Furthermore, their mechanism of action was investigated through in vitro kinetics studies which revealed compounds 3a, 3d, 3o, and 2k as competitive inhibitors, and 3f as a mixed type inhibitor of alpha-glucosidase. In addition, in silico molecular docking and molecular dynamics simulations were applied to observe the mode of interaction of the active hits within the binding pocket of alpha-glucosidase. Both docking and simulation results favored our in vitro mechanistic analysis.
引用
收藏
页数:16
相关论文
共 59 条
[1]   Synthesis, crystal structure and Hirshfeld Surface analysis of benzamide derivatives of thiourea as potent inhibitors of α-glucosidase in-vitro [J].
Akhter, Sidra ;
Ullah, Saeed ;
Yousuf, Sammer ;
Atia-tul-Wahab ;
Siddiqui, Hina ;
Choudhary, M. Iqbal .
BIOORGANIC CHEMISTRY, 2021, 107
[2]   Exploring Drug-Related Problems in Diabetic Patients during Ramadan Fasting in Saudi Arabia: A Mixed-Methods Study [J].
Alluqmani, Waleed Saleh ;
Alotaibi, Mohammed Misri ;
Almalki, Waleed Jamal ;
Althaqafi, Abdulrahman ;
Alawi, Hamed Abdullah ;
Althobiani, Fahad ;
Albishi, Amjad Abdullah ;
Madkhali, Amjad Ahmad ;
Baunes, Layal Yahia ;
Alhazmi, Razan Ibrahim ;
Doman, Elaf Mohammed ;
Alhazmi, Anwar Hussain ;
Ali, Majid ;
Cheema, Ejaz .
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2019, 16 (03)
[3]   3. Foundations of Care and Comprehensive Medical Evaluation [J].
不详 .
DIABETES CARE, 2016, 39 :S23-S35
[4]   Synthesis of some new [1,2,4]triazolo[3,4-b][1,3,4]thiadiazines and [1,2,4]triazolo[3,4-b][1,3,4] thiadiazoles starting from 5-nitro-2-furoic acid and evaluation of their antimicrobial activity [J].
Badr, Sahar M. I. ;
Barwa, Rasha M. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (15) :4506-4512
[5]   Naturally Available Nitrogen-Containing Fused Heterocyclics as Prospective Lead Molecules in Medicinal Chemistry [J].
Bhardwaj, Nivedita ;
Pathania, Akashdeep ;
Kumar, Pradeep .
CURRENT TRADITIONAL MEDICINE, 2021, 7 (01) :5-27
[6]   The gut microbiome as a target for prevention and treatment of hyperglycaemia in type 2 diabetes: from current human evidence to future possibilities [J].
Brunkwall, Louise ;
Orho-Melander, Marju .
DIABETOLOGIA, 2017, 60 (06) :943-951
[7]  
C.C.G. ULC, 2020, Molecular Operating Environment (MOE), 2020.09, 1010 Sherbrooke St. West, Suite #910
[8]  
Community B.O., 2018, BLENDER A 3D MODELLI
[9]  
Dighe A.S., 2020, Synthesis and Analysis of Novel Triazolo Thiadiazole Derivatives as a Biological Interest
[10]  
Gajbhiye R L., 2018, Annals Of Clinical Pharmacology And Therapeutics, V1, P1